← Back to Clinical Trials
Recruiting NCT06833762

NCT06833762 Clinical and CPET Parameters That Predict Improvement in Functional Capacity After TAVI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06833762
Status Recruiting
Phase —
Sponsor Hospital Clinic of Barcelona
Condition Aortic Stenosis Disease
Study Type OBSERVATIONAL
Enrollment 161 participants
Start Date 2025-01-01
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 161 participants in total. It began in 2025-01-01 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Determining Clinical and Cardiopulmonary exercise testing Parameters that may predict Improvement in Capacity After Transcatheter Aortic Valve Implantation

Eligibility Criteria

Inclusion Criteria: * All those patients ≥ 18 years of age with severe aortic stenosis approved for transfemoral TAVI. Both sexes, male and female will be included in the study. Exclusion Criteria: Very severe aortic stenosis, defined as a valve area of ≤0.6 cm2 , mean gradient ≥60 mmHg or Vmax \>5 m/s * Previous syncope * Proven exercise-induced arrhythmias * Previously known dynamic left ventricular outflow tract (LVOT) obstruction, defined as LVOT gradient of ≥ 30 mmHg by echocardiography * Concomitant coronary artery disease pending percutaneous coronary intervention * Inability to consent * Physical limitation to perform an exercise test * Non-elective procedure * Valve-in-valve procedure

Contact & Investigator

Central Contact

Marc Giménez-Milà

✉ magimene@clinic.cat

📞 696762626

Frequently Asked Questions

Who can join the NCT06833762 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Stenosis Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06833762 currently recruiting?

Yes, NCT06833762 is actively recruiting participants. Contact the research team at magimene@clinic.cat for enrollment information.

Where is the NCT06833762 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT06833762 clinical trial?

NCT06833762 is sponsored by Hospital Clinic of Barcelona. The trial plans to enroll 161 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology